Literature DB >> 19021075

Cognitive changes in asymptomatic drug-naïve human immunodeficiency virus type 1 clade C infection.

K Gopukumar1, Shobini L Rao, P Satishchandra, Jayashree Dasgupta, Ronald J Ellis, D K Subbakrishna, P Mariamma, Anupa Kamat, Anita Desai, V Ravi, B S Rao, K S Satish, Mahendra Kumar.   

Abstract

Asymptomatic human immunodeficiency virus (HIV) infection is associated with impaired cognitive functioning in both clade B and C infections. The nature of cognitive change longitudinally has not been studied in asymptomatic clade C infection. The present study evaluated changes in neuropsychological functioning over a 2(1/2)-year period in a cohort of HIV-1 clade C-infected asymptomatic individuals from South India. Participants with CD4 counts below 250 were started on highly active antiretroviral therapy (HAART) as per National AIDS Control Organisation NACO guidelines and hence excluded. The sample consisted of 68 patients (30 men and 38 women), with a mean age of 29.4 years (SD=5.6 years) and a mean education of 10.0 years (SD=2.7 years). A comprehensive neuropsychological assessment with 12 tests yielding 21 variables was used to examine cognitive functioning at baseline and subsequently at 6-monthly intervals for five follow-ups. Shift in CD4 and viral load categories measured by the McNemar's test indicated disease progression. Latent growth curve (LGC) modeling assessed the nature of change in cognition over the 2(1/2)-year study period. Ten variables representing attention, executive functions, and long-term memory fit the LGC model. Excepting visual working memory, the slope was nonsignificant for nine variables, indicating absence of deterioration in cognition over a 2(1/2)-year period. However, CD4 and viral load levels worsened, indicating disease progression. Asymptomatic individuals with HIV-1 clade C infection do not show any significant decline on individual neuropsychological functions over 2(1/2) years despite disease progression, as evidenced by immune suppression and viral loads.

Entities:  

Mesh:

Year:  2008        PMID: 19021075     DOI: 10.1080/13550280802304746

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  11 in total

Review 1.  Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 infected individuals. The HNRC Group. HIV Neurobehavioral Research Center.

Authors:  D A White; R K Heaton; A U Monsch
Journal:  J Int Neuropsychol Soc       Date:  1995-05       Impact factor: 2.892

2.  Latent growth curves within developmental structural equation models.

Authors:  J J McArdle; D Epstein
Journal:  Child Dev       Date:  1987-02

3.  HIV-1 infection: no evidence of cognitive decline during the asymptomatic stages. The Multicenter AIDS Cohort Study.

Authors:  O A Selnes; E Miller; J McArthur; B Gordon; A Muñoz; K Sheridan; R Fox; A J Saah
Journal:  Neurology       Date:  1990-02       Impact factor: 9.910

4.  The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center.

Authors:  R K Heaton; I Grant; N Butters; D A White; D Kirson; J H Atkinson; J A McCutchan; M J Taylor; M D Kelly; R J Ellis
Journal:  J Int Neuropsychol Soc       Date:  1995-05       Impact factor: 2.892

5.  Neurocognitive consequences of HIV in southern India: a preliminary study of clade C virus.

Authors:  Tokugha Yepthomi; Robert Paul; Snigdha Vallabhaneni; N Kumarasamy; David F Tate; Suniti Solomon; Timothy Flanigan
Journal:  J Int Neuropsychol Soc       Date:  2006-05       Impact factor: 2.892

6.  Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging.

Authors:  I Grant; J H Atkinson; J R Hesselink; C J Kennedy; D D Richman; S A Spector; J A McCutchan
Journal:  Ann Intern Med       Date:  1987-12       Impact factor: 25.391

7.  Changes in neuropsychological functioning with progression of HIV-1 infection: results of an 8-year longitudinal investigation.

Authors:  Teri T Baldewicz; Jane Leserman; Susan G Silva; John M Petitto; Robert N Golden; Diana O Perkins; Julie Barroso; Dwight L Evans
Journal:  AIDS Behav       Date:  2004-09

8.  Quantitation of HIV-1 RNA levels in plasma and CSF of asymptomatic HIV-1 infected patients from South India using a TaqMan real time PCR assay.

Authors:  Anupa Kamat; V Ravi; Anita Desai; P Satishchandra; K S Satish; I Borodowsky; D K Subbakrishna; Mahendra Kumar
Journal:  J Clin Virol       Date:  2007-03-23       Impact factor: 3.168

9.  Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India.

Authors:  Jayashree Das Gupta; P Satishchandra; Kumarpillai Gopukumar; Frances Wilkie; Drenna Waldrop-Valverde; Ronald Ellis; Raymond Ownby; D K Subbakrishna; Anita Desai; Anupa Kamat; V Ravi; B S Rao; K S Satish; Mahendra Kumar
Journal:  J Neurovirol       Date:  2007-06       Impact factor: 2.643

10.  Cognitive impairment in asymptomatic stages of HIV infection. A longitudinal study.

Authors:  G Villa; A Solida; E Moro; M Tavolozza; A Antinori; A De Luca; R Murri; E Tamburrini
Journal:  Eur Neurol       Date:  1996       Impact factor: 1.710

View more
  3 in total

1.  Impact of the HIV Tat C30C31S dicysteine substitution on neuropsychological function in patients with clade C disease.

Authors:  Robert H Paul; John A Joska; Carol Woods; Soraya Seedat; Susan Engelbrecht; Jacqueline Hoare; Jodi Heaps; Victor Valcour; Beau Ances; Laurie M Baker; Lauren E Salminen; Dan J Stein
Journal:  J Neurovirol       Date:  2014-11-01       Impact factor: 2.643

2.  Peripheral biomarkers do not correlate with cognitive impairment in highly active antiretroviral therapy-treated subjects with human immunodeficiency virus type 1 infection.

Authors:  Bing Sun; Linda Abadjian; Hans Rempel; Cyrus Calosing; Johannes Rothlind; Lynn Pulliam
Journal:  J Neurovirol       Date:  2010-03       Impact factor: 2.643

3.  HIV and mental health: An overview of research from India.

Authors:  Nishanth Jayarajan; Prabha S Chandra
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.